Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements

Overview

Journal Mol Biotechnol

Publisher Springer

Specialties Biotechnology
Molecular Biology

Date 2024 Jun 27

PMID 38935260

Authors

Shadi Ghorbanzadeh

Javad Yaghmoorian Khojini

Reza Abouali

Sajad Alimardan

Mohammad Zahedi

Zahra Tahershamsi

Amir Tajbakhsh

Seyed Mohammad Gheibihayat

Affiliations

Soon will be listed here.

Abstract

Inflammatory and autoimmune disorders, characterized by dysregulated immune responses leading to tissue damage and chronic inflammation, present significant health challenges. This review uniquely focuses on efferocytosis-the phagocyte-mediated clearance of apoptotic cells-and its pivotal role in these disorders. We delve into the intricate mechanisms of efferocytosis' four stages and their implications in disease pathogenesis, distinguishing our study from previous literature. Our findings highlight impaired efferocytosis in conditions like atherosclerosis and asthma, proposing its targeting as a novel therapeutic strategy. We discuss the therapeutic potential of efferocytosis in modulating immune responses and resolving inflammation, offering a new perspective in treating inflammatory disorders.

References

Szondy Z, Garabuczi E, Joos G, Tsay G, Sarang Z . Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications. Front Immunol. 2014; 5:354. PMC: 4117929. DOI: 10.3389/fimmu.2014.00354. View

Han M, Ryu G, Shin S, An J, Kim H, Park D . Physiological Roles of Apoptotic Cell Clearance: Beyond Immune Functions. Life (Basel). 2021; 11(11). PMC: 8621940. DOI: 10.3390/life11111141. View

Arandjelovic S, Ravichandran K . Phagocytosis of apoptotic cells in homeostasis. Nat Immunol. 2015; 16(9):907-17. PMC: 4826466. DOI: 10.1038/ni.3253. View

Kourtzelis I, Hajishengallis G, Chavakis T . Phagocytosis of Apoptotic Cells in Resolution of Inflammation. Front Immunol. 2020; 11:553. PMC: 7137555. DOI: 10.3389/fimmu.2020.00553. View

Doran A, Yurdagul Jr A, Tabas I . Efferocytosis in health and disease. Nat Rev Immunol. 2019; 20(4):254-267. PMC: 7667664. DOI: 10.1038/s41577-019-0240-6. View

Abdolmaleki F, Farahani N, Gheibi Hayat S, Pirro M, Bianconi V, Barreto G . The Role of Efferocytosis in Autoimmune Diseases. Front Immunol. 2018; 9:1645. PMC: 6064952. DOI: 10.3389/fimmu.2018.01645. View

Gheibi Hayat S, Bianconi V, Pirro M, Sahebkar A . Efferocytosis: molecular mechanisms and pathophysiological perspectives. Immunol Cell Biol. 2018; 97(2):124-133. DOI: 10.1111/imcb.12206. View

Mike E, Makinde H, Der E, Stock A, Gulinello M, Gadhvi G . Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling. Front Immunol. 2018; 9:2189. PMC: 6168636. DOI: 10.3389/fimmu.2018.02189. View

Thorp E, Cui D, Schrijvers D, Kuriakose G, Tabas I . Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler Thromb Vasc Biol. 2008; 28(8):1421-8. PMC: 2575060. DOI: 10.1161/ATVBAHA.108.167197. View

10.

Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y . Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004; 304(5674):1147-50. DOI: 10.1126/science.1094359. View

11.

Waterborg C, Koenders M, van Lent P, van der Kraan P, van de Loo F . Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis. PLoS One. 2018; 13(10):e0205902. PMC: 6193696. DOI: 10.1371/journal.pone.0205902. View

12.

Le Lam A, Heit B . Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes. Cells. 2021; 10(5). PMC: 8161178. DOI: 10.3390/cells10051265. View

13.

Cohen P, Caricchio R, Abraham V, Camenisch T, Jennette J, Roubey R . Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med. 2002; 196(1):135-40. PMC: 2194017. DOI: 10.1084/jem.20012094. View

14.

Roszer T, Menendez-Gutierrez M, Lefterova M, Alameda D, Nunez V, Lazar M . Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol. 2010; 186(1):621-31. PMC: 4038038. DOI: 10.4049/jimmunol.1002230. View

15.

van der Veen T, de Groot L, Melgert B . The different faces of the macrophage in asthma. Curr Opin Pulm Med. 2019; 26(1):62-68. PMC: 6903353. DOI: 10.1097/MCP.0000000000000647. View

16.

Martinez J, Cook D . What's the deal with efferocytosis and asthma?. Trends Immunol. 2021; 42(10):904-919. PMC: 9843639. DOI: 10.1016/j.it.2021.08.004. View

17.

Hochreiter-Hufford A, Ravichandran K . Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb Perspect Biol. 2013; 5(1):a008748. PMC: 3579390. DOI: 10.1101/cshperspect.a008748. View

18.

Poon I, Lucas C, Rossi A, Ravichandran K . Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol. 2014; 14(3):166-80. PMC: 4040260. DOI: 10.1038/nri3607. View

19.

Kawano M, Nagata S . Efferocytosis and autoimmune disease. Int Immunol. 2018; 30(12):551-558. PMC: 6234909. DOI: 10.1093/intimm/dxy055. View

20.

Ravichandran K . Find-me and eat-me signals in apoptotic cell clearance: progress and conundrums. J Exp Med. 2010; 207(9):1807-17. PMC: 2931173. DOI: 10.1084/jem.20101157. View